Yulia I. Vecherskaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yulia I. Vecherskaya has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr Petrovich Trashkov
NRC “Kurchatov Institute
5 shared publications - Alexander I. Budko
NRC “Kurchatov Institute
5 shared publications - Anna A. Prokhorycheva
NRC “Kurchatov Institute
5 shared publications - Andrey Glebovich Vasiliev
St. Petersburg State Pediatric Medical University
3 shared publications - Mariya A. Pakhomova
Saint Petersburg State Pediatric Medical University
2 shared publications - Olga M. Ignatova
National research center “Kurchatov Institute
2 shared publications
Latest Publications
- 1 June 2026
- Published by LLC Institute Information Technologies
AQUAPORIN-4 AND OLFACTOMEDIN-4 AS POTENTIAL BIOMARKERS OF INJURY SEVERITY AND NEURORECOVERY IN A CLOSED TRAUMATIC BRAIN INJURY MODEL
In a rat model of closed TBI (Wistar, n=101), the potential of aquaporin-4 (AQP4) and olfactomedin-4 (OLFM4) in brain tissue homogenates as biomarkers of injury severity and recovery dynamics was assessed. AQP4 demonstrated sensitivity to the acute astrocytic response and its pharmacological modulation. OLFM4 showed a biphasic pattern — a decrease in the acute phase followed by a gradual increase, the rate of which depended on the type of neuroprotective therapy (citicoflavin, cerebrolysin)
- 1 June 2026
- Published by LLC Institute Information Technologies
AQUAPORIN-4 AND OLFACTOMEDIN-4 AS POTENTIAL BIOMARKERS OF INJURY SEVERITY AND NEURORECOVERY IN A CLOSED TRAUMATIC BRAIN INJURY MODEL
In a rat model of closed TBI (Wistar, n=101), the potential of aquaporin-4 (AQP4) and olfactomedin-4 (OLFM4) in brain tissue homogenates as biomarkers of injury severity and recovery dynamics was assessed. AQP4 demonstrated sensitivity to the acute astrocytic response and its pharmacological modulation. OLFM4 showed a biphasic pattern — a decrease in the acute phase followed by a gradual increase, the rate of which depended on the type of neuroprotective therapy (citicoflavin, cerebrolysin)
- 1 June 2026
- Published by LLC Institute Information Technologies
ASSESSMENT OF COAGULATION HEMOSTASIS IN THE DEVELOPMENT OF EXPERIMENTAL METASTATIC COLORECTAL CANCER WITH DIFFERENT PROLIFERATIVE ACTIVITY
This study evaluates changes in hemostasis parameters during the development of experimental models of metastatic colorectal cancer (mCRC) in laboratory animals. It was found that tumor progression was accompanied with the formation of a hypercoagulable state, manifested by a decrease in activated partial thromboplastin time (APTT), prothrombin time, and thrombin time, as well as an increase in fibrinogen levels in the blood. The severity of the observed changes increased over time and varied depending on the tumor model.
- 1 June 2026
- Published by LLC Institute Information Technologies
ASSESSMENT OF COAGULATION HEMOSTASIS IN THE DEVELOPMENT OF EXPERIMENTAL METASTATIC COLORECTAL CANCER WITH DIFFERENT PROLIFERATIVE ACTIVITY
This study evaluates changes in hemostasis parameters during the development of experimental models of metastatic colorectal cancer (mCRC) in laboratory animals. It was found that tumor progression was accompanied with the formation of a hypercoagulable state, manifested by a decrease in activated partial thromboplastin time (APTT), prothrombin time, and thrombin time, as well as an increase in fibrinogen levels in the blood. The severity of the observed changes increased over time and varied depending on the tumor model.
- 1 June 2026
- Published by LLC Institute Information Technologies
AQPORINS IN THE PATHOGENESIS OF EXPERIMENTAL GLIOBLASTOMA
In the article, the authors examine the changes in the dynamics of aquaporin family protein accumulation in relation to the degree of development of human glioblastoma. During the experiment, a hypothesis was proposed regarding the uneven progression of the malignant neoplasm and the role of aquaporin family proteins in the accumulation of nutrients necessary for tumor growth.
- 1 June 2026
- Published by LLC Institute Information Technologies
AQPORINS IN THE PATHOGENESIS OF EXPERIMENTAL GLIOBLASTOMA
In the article, the authors examine the changes in the dynamics of aquaporin family protein accumulation in relation to the degree of development of human glioblastoma. During the experiment, a hypothesis was proposed regarding the uneven progression of the malignant neoplasm and the role of aquaporin family proteins in the accumulation of nutrients necessary for tumor growth.
- Open Access
- 19 December 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 15 (6) , 49-61
Models of traumatic brain injury: modern approaches, classification, and research perspectives
Traumatic brain injury represents one of the most complex biomedical challenges, affecting millions of people worldwide each year. Various experimental and theoretical models are used to understand the pathophysiology of traumatic brain injury and to develop effective therapeutic strategies. This review focuses on three main groups of models: theoretical (in silico), cellular (in vitro), and animal (in vivo). Theoretical models of traumatic brain injury are based on mathematical approaches and computer simulations to analyze mechanical brain injuries, edema processes, ischemia, and neuroinflammation. In silico approaches provide high precision and reproducibility but require proper validation with biological data. Cellular models include the cultivation of neurons, astrocytes, microglia, and brain organoids, which are subjected to mechanical or chemical factors that mimic traumatic brain injury. These systems allow researchers to study cellular and molecular mechanisms such as apoptosis, neuroinflammation, and regeneration. However, in vitro models are limited by the absence of a systemic response characteristic of an entire organism. Animal models are considered the “gold standard” for studying traumatic brain injury. These involve direct mechanical impacts on the brains of animals (e.g., mice, rats, pigs), enabling the reproduction of clinical aspects of trauma, including behavioral and pathophysiological changes. Despite their high physiological relevance, in vivo models face ethical limitations and challenges in extrapolating results to humans. This article provides an overview of modern approaches to traumatic brain injury modeling, including their classification, characteristics, advantages, and limitations. The data presented may serve as a foundation for developing more effective treatment and rehabilitation strategies for traumatic brain injury patients.
- 19 December 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 15 (6) , 49-61
Open AccessModels of traumatic brain injury: modern approaches, classification, and research perspectives
Traumatic brain injury represents one of the most complex biomedical challenges, affecting millions of people worldwide each year. Various experimental and theoretical models are used to understand the pathophysiology of traumatic brain injury and to develop effective therapeutic strategies. This review focuses on three main groups of models: theoretical (in silico), cellular (in vitro), and animal (in vivo). Theoretical models of traumatic brain injury are based on mathematical approaches and computer simulations to analyze mechanical brain injuries, edema processes, ischemia, and neuroinflammation. In silico approaches provide high precision and reproducibility but require proper validation with biological data. Cellular models include the cultivation of neurons, astrocytes, microglia, and brain organoids, which are subjected to mechanical or chemical factors that mimic traumatic brain injury. These systems allow researchers to study cellular and molecular mechanisms such as apoptosis, neuroinflammation, and regeneration. However, in vitro models are limited by the absence of a systemic response characteristic of an entire organism. Animal models are considered the “gold standard” for studying traumatic brain injury. These involve direct mechanical impacts on the brains of animals (e.g., mice, rats, pigs), enabling the reproduction of clinical aspects of trauma, including behavioral and pathophysiological changes. Despite their high physiological relevance, in vivo models face ethical limitations and challenges in extrapolating results to humans. This article provides an overview of modern approaches to traumatic brain injury modeling, including their classification, characteristics, advantages, and limitations. The data presented may serve as a foundation for developing more effective treatment and rehabilitation strategies for traumatic brain injury patients.
- 19 December 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 15 (6) , 63-71
The glymphatic system: methods of study, role in neurodegenerative diseases and brain tumors
The glymphatic system is a newly discovered macroscopic system for the excretion of soluble proteins and metabolites of the central nervous system, first described in vivo in 2012. It is formed by aquaporin-4 proteins in the legs of astroglial cells and uses a system of perivascular tunnels. From the first description to the present day, many extensive studies of the glymphatic system have been conducted, but there are still many unresolved issues. Most of the work described the composition of the glymphatic system, and recently, the genetic apparatuses responsible for the functioning of functional units responsible for the stable functioning of the system have also been actively studied. To date, disorders in the work of the glymphatic system are considered as a risk factor for the development of age-related brain changes, neurovascular and neurodegenerative diseases, as well as impaired recovery from injuries to the brain. Many studies have highlighted the relationship between glymphatic system dysfunction and neurodegeneration associated with traumatic brain injury. There is also a part of the work devoted to the role of glymphatic system in the development of peritumoral edema in tumors of brain. However, so far, there is insufficient data on the role of glymphatic system in the localization of primary and secondary brain tumors. The purpose of this review is to summarize the currently available results in the scientific community on the composition of glymphatic system, its visualization methods, and its role both in the normal state of the body and in pathological processes: traumatic brain injuries, neurodegenerative diseases and malignant neoplasms of the brain.
- 19 December 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 15 (6) , 63-71
The glymphatic system: methods of study, role in neurodegenerative diseases and brain tumors
The glymphatic system is a newly discovered macroscopic system for the excretion of soluble proteins and metabolites of the central nervous system, first described in vivo in 2012. It is formed by aquaporin-4 proteins in the legs of astroglial cells and uses a system of perivascular tunnels. From the first description to the present day, many extensive studies of the glymphatic system have been conducted, but there are still many unresolved issues. Most of the work described the composition of the glymphatic system, and recently, the genetic apparatuses responsible for the functioning of functional units responsible for the stable functioning of the system have also been actively studied. To date, disorders in the work of the glymphatic system are considered as a risk factor for the development of age-related brain changes, neurovascular and neurodegenerative diseases, as well as impaired recovery from injuries to the brain. Many studies have highlighted the relationship between glymphatic system dysfunction and neurodegeneration associated with traumatic brain injury. There is also a part of the work devoted to the role of glymphatic system in the development of peritumoral edema in tumors of brain. However, so far, there is insufficient data on the role of glymphatic system in the localization of primary and secondary brain tumors. The purpose of this review is to summarize the currently available results in the scientific community on the composition of glymphatic system, its visualization methods, and its role both in the normal state of the body and in pathological processes: traumatic brain injuries, neurodegenerative diseases and malignant neoplasms of the brain.